What are the treatment options for a reaction to a cortisone (corticosteroid) injection in the foot?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Corticosteroid Injection Reactions in the Foot

For a reaction to a cortisone injection in the foot, immediately stop any further injections, assess the severity of symptoms, and treat mild reactions (pain, swelling, redness) with ice, NSAIDs, and observation, while moderate-to-severe reactions (hypotension, respiratory symptoms, widespread urticaria) require immediate epinephrine 0.3 mg IM, IV fluids, and emergency medical evaluation. 1

Immediate Assessment and Classification

When a patient presents with a reaction following foot corticosteroid injection, rapidly classify the severity:

Mild Reactions

  • Localized injection site pain, swelling, or erythema 2
  • Pruritus limited to injection area 1
  • Facial flushing or sweating (common steroid side effect) 1
  • Back pain or joint pain 1

Moderate Reactions

  • Mild symptoms PLUS transient cough, shortness of breath, or tachycardia 1
  • Hypotension (drop in systolic BP ≥30 mmHg from baseline or SBP ≤90 mmHg) 1
  • Localized urticaria spreading beyond injection site 1

Severe/Life-Threatening Reactions (Anaphylaxis)

  • Sudden onset with rapid symptom intensification 1
  • Loss of consciousness 1
  • Angioedema of tongue or airway 1
  • Involvement of two or more organ systems (cardiovascular, respiratory, skin, gastrointestinal) 1

Treatment Protocol by Severity

For Mild Reactions

Stop any ongoing treatment and monitor for 15 minutes. 1 Most mild reactions are self-limiting and resolve spontaneously. 1

  • Apply ice through a wet towel for 10-minute periods to reduce pain and swelling 3, 4
  • Administer oral NSAIDs for pain relief (topical NSAIDs preferred to avoid gastrointestinal side effects) 3, 4
  • Maintain IV access with normal saline at keep-vein-open rate if in clinical setting 1
  • Continue monitoring vital signs (BP, pulse, respiratory rate, O2 saturation) until stable 1

If symptoms persist beyond 15 minutes or worsen: Consider IV hydrocortisone 100-500 mg (or equivalent) and IV H2 antagonist such as famotidine 20 mg. 1

For Moderate Reactions

Immediately stop any injection, switch IV line to normal saline, and notify physician. 1

  • Recline patient onto back if hypotensive 1
  • Administer NS bolus of 1000-2000 mL for hypotension 1
  • Give oxygen by mask or nasal cannula if hypoxemic 1
  • Administer IV corticosteroid: hydrocortisone 100-500 mg IV 1
  • Consider IV H2 antagonist: famotidine 20 mg IV 1
  • Monitor continuously for at least 15 minutes and reassess 1

Symptom-directed treatment:

  • For nausea: ondansetron 4-8 mg IV 1
  • For urticaria: second-generation antihistamine (loratadine 10 mg PO or cetirizine 10 mg IV/PO) 1
  • Avoid first-generation antihistamines like diphenhydramine as they can exacerbate hypotension, tachycardia, and sedation 1

For Severe Reactions/Anaphylaxis

Immediately call emergency services or resuscitation team. 1

  • Administer epinephrine (1 mg/mL) 0.3 mg IM into anterolateral mid-thigh immediately 1
  • May repeat epinephrine once if no improvement 1
  • Recline patient flat and elevate legs 1
  • Administer aggressive IV fluid resuscitation: NS bolus 1000-2000 mL 1
  • Provide high-flow oxygen 1
  • Consider β2 agonist nebulizer: albuterol 0.083% via nebulizer for bronchospasm 1
  • Continuous monitoring of vital signs 1

Post-Reaction Management

Patient Education on Delayed Reactions

Educate patients that delayed reactions can occur hours to days after injection, including: 1

  • Flu-like symptoms, arthralgias, myalgias, and fever (typically lasting up to 24 hours) 1
  • These delayed symptoms are easily managed with NSAIDs 1
  • Symptoms persisting beyond a few days require medical evaluation to rule out other pathologies 1

Common Injection Site Reactions (Not True Allergic Reactions)

Most injection site reactions are not immunogenic or allergic and include: 2

  • Localized pain, swelling, erythema at injection site (reported in 1.3-14% of foot/ankle injections) 1, 5
  • "Steroid flare" - temporary worsening of pain within 24-48 hours post-injection 5
  • These reactions do not correlate with drug efficacy or development of antidrug antibodies 2

Management of steroid flare: Ice application, oral NSAIDs, and reassurance that symptoms typically resolve within 48 hours. 3, 4

Critical Safety Considerations

Prevention of Future Reactions

  • Never inject corticosteroids directly into tendon substance - only peritendinous injection is safe, as intratendinous injection reduces tensile strength and predisposes to spontaneous rupture 3, 6, 4
  • Use ultrasound guidance to ensure proper anatomical placement and avoid neurovascular structures 6, 7
  • Limit to maximum 2-3 corticosteroid injections before considering alternative treatments 6

Serious Complications (Rare)

While rare, be aware of potential serious complications: 1, 5

  • Infection (extremely rare - no infections reported in series of 365 foot/ankle injections) 5
  • Plantar plate rupture (reported in <1% of cases) 5
  • Transient sciatic nerve block from anterior capsular disruption (can occur with sacroiliac injections) 1

Systemic Corticosteroid Effects

Even with local injection, systemic absorption can occur, potentially causing: 1, 8

  • Hyperglycemia (particularly important in diabetic patients) 1
  • Immunosuppression with increased infection risk 1, 8
  • Hypothalamic-pituitary axis suppression 1
  • Decreased bone mineral density with prolonged use 1

When Reactions Are NOT Contraindications to Treatment

Important: Most injection site reactions (pain, swelling, erythema) are not true allergic reactions and do not necessitate discontinuation of corticosteroid therapy. 2 Misunderstanding the pathophysiology may result in unnecessary treatment discontinuation. 2

However, true anaphylaxis is an absolute contraindication to future use of that specific corticosteroid formulation. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Lateral Foot Tendinitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Management for Biceps Tendinosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Efficacy of Foot and Ankle Corticosteroid Injections.

Foot & ankle international, 2017

Guideline

Methylprednisolone for De Quervain's Tenosynovitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Short-term benefits of ultrasound-guided corticosteroid injection in plantar fasciitis.

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine, 2013

Research

Systemic corticosteroid therapy--side effects and their management.

The British journal of ophthalmology, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.